1 citations
,
January 2017 in “Social Science Research Network” This study found that repealing tampon taxes in New Jersey predominantly benefited low-income consumers, making menstrual hygiene products more accessible to them, while high-income consumers shared the tax break with producers.
July 2026 in “Pharmacological Reports” In this pilot study, topical latanoprost acid was observed to increase hair count and improve hair follicle structure in women with androgenetic alopecia, with no serious adverse events, suggesting potential for further investigation to confirm its efficacy and safety.
September 2026 in “Journal of Periodontal Research” In this narrative review, the authors found epidemiological evidence suggesting a positive link between periodontitis and psoriasis, with treatment for periodontitis potentially reducing psoriasis severity over the short term, though causality and mechanisms remain unclear.
September 2026 in “Journal of Cosmetic Dermatology” This scoping review reports that preclinical studies suggest omega fatty acids may promote hair follicle growth, but clinical evidence is mixed, with no support for their standalone use in treating alopecia.
August 2026 in “International Journal of Drug Delivery Technology” July 2026 in “Anais Brasileiros de Dermatologia” This research observed that nanocarrier formulations of minoxidil improve follicular targeting and hair-growth outcomes in experimental settings, but their clinical efficacy and safety for treating androgenetic alopecia in patients remain unverified, necessitating further randomized clinical trials.
July 2026 in “Journal of the American Academy of Dermatology” Severe alopecia areata in children greatly affects their mental and social well-being, and addressing these challenges is crucial.
June 2026 in “International Journal of Innovative Science and Research Technology (IJISRT)” This review explores both traditional Ayurvedic uses and modern scientific findings on Japa Pushpa (Hibiscus rosa-sinensis), suggesting it may benefit cardiovascular health and metabolic balance as a herbal tea, but emphasizes the need for further clinical validation.
June 2026 in “Homo Politicus (Academy of Humanities and Economics in Lodz)” The effectiveness of ingredients in anti-hair loss products varies, and clinical trials are crucial to determine their success.
June 2026 in “JAAD reviews.” This review suggests that low-dose oral minoxidil may enhance hair density in certain nonandrogenetic alopecias, but highlights the need for controlled trials due to mixed and limited evidence.
June 2026 in “The Journal of Sexual Medicine” This study found that psychiatric adverse drug reactions were more frequently reported with finasteride than with dutasteride, but it remains unclear if there is a causal relationship.
May 2026 in “Indian Journal of Medical Biochemistry” This review highlights that hair cortisol levels, linked to pregnancy changes and higher in conditions like PCOS, are promising stress biomarkers in female reproductive health, though further research is needed.
April 2026 in “Brain Sciences” This pharmacovigilance study analyzed FAERS data and found that finasteride is more frequently associated with neuropsychiatric reactions like depression and suicide risk, especially in younger men using it for alopecia, compared to dutasteride.
In this study, topical latanoprost acid applied daily for 6 months increased hair count and improved trichoscopic markers among women with hair loss, suggesting its potential for treating female androgenetic alopecia, particularly at a 0.05% concentration.
March 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study confirmed that minoxidil is effective for female androgenic alopecia, with suggested additional benefits from therapies like LLLT and PRP, although more research is needed.
March 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study confirms minoxidil's effectiveness for treating female androgenic alopecia and suggests possible added benefits from therapies like LLLT and PRP, though further research is needed.
In this narrative review, researchers synthesized current evidence on topical metformin's potential benefits for various skin conditions, citing primarily preclinical studies that highlight its anti-inflammatory, antioxidant, and regenerative properties, although clinical translation requires further rigorous trials.
January 2026 in “Cronfa (Swansea University)” Finasteride and dutasteride may increase the risk of depression and suicidality, so patients should be monitored closely.
January 2026 in “Open Science Framework” This research outlines a protocol for a systematic review to map the evidence on alopecia areata in Sub-Saharan Africa, aiming to identify research gaps and guide future studies and policy decisions related to this condition in the region.
December 2025 in “Journal of Integrated Standardized Homoeopathy” This case report describes the use of individualized homoeopathic treatment and dietary modifications to manage hypothyroidism in a 23-year-old woman, resulting in symptom improvement and normalized TSH levels after tapering off levothyroxine.
December 2025 in “International Journal of Molecular Sciences” This review examined 40 studies on exosome-based therapies for alopecia areata, reporting significant hair regrowth and improvements in hair count, length, and thickness, but highlighted the need for standardized methodologies and robust RCTs before clinical application.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” Microneedling may help regrow eyebrow hair, but more research is needed.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” Microneedling may help eyebrow hair growth, but more research is needed.
November 2025 in “Eurasian journal of applied biotechnology” This study found that 15 clinical trials have been registered to investigate the use of mesenchymal stem cell-derived exosomes for treating skin and subcutaneous tissue diseases, particularly alopecia, with a growing global interest and most trials conducted in the United States and China.
November 2025 in “Cosmetics” This review discusses the clinical efficacy, safety, and mechanisms of Autologous Micrografting Technology for androgenetic alopecia, reporting significant short-term improvements in hair density and thickness.
August 2025 in “Skin Appendage Disorders” This review highlights that while low-dose oral minoxidil appears well-tolerated in cancer patients post-chemotherapy, its use during active chemotherapy has shown potential benefits but remains under investigation, with preclinical studies suggesting a protective effect against chemotherapy-induced alopecia.
June 2025 in “Electronic Journal of General Medicine” This review suggests that melatonin may increase hair density and reduce hair shedding, but variations in study designs highlight the need for more standardized clinical trials.
This systematic review examined the potential of microneedling for anterior neck scars but found no eligible studies directly investigating this application. Indirect evidence from other body regions suggests possible benefits, underscoring the need for targeted research to validate these findings for neck surgery patients.
April 2025 in “Journal of Pharmacy and Pharmacology” This study reviewed how certain phytochemicals can stimulate hair follicles, promote keratinocyte proliferation, and engage specific signaling pathways like Wnt/β-catenin and AKT, suggesting these natural compounds may offer safer alternatives for promoting hair growth. However, challenges in bioavailability and formulation standardization remain to be addressed.
April 2025 in “Journal of Cosmetic Dermatology” This study suggests potential causal associations between certain lipid levels, specifically HDL-C and triglycerides, and alopecia areata, highlighting the importance of lipid management as a therapeutic target.